康方生物否认向患者销售“临床研究用药”:销售人员伪造材料从公司骗取若干药物

澎湃新闻
Jun 04, 2025

近日,“流入市场的临床试验抗癌药”引发行业关注,涉及到的药物正是康方生物的卡度尼利单抗。6月4日,康方生物向记者提供的《关于重庆某宫颈癌患者使用公司药物相关新闻报道的声明》称,经调查核实:对于患者李某美使用的临床研究药物,公司从未向患者李某美收取任何费用,公司经办销售人员亦未收取患者李某美的任何费用。即不存在患者“花钱购买了临床研究用药”的情况。声明提到,公司重庆销售人员通过伪造研究立项文件及医院...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10